Related references
Note: Only part of the references are listed.Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
Giulio Francesco Romiti et al.
ECLINICALMEDICINE (2023)
Racial and Ethnic Disparities in Stroke Prevention for Atrial Fibrillation
Peter Calvert et al.
AMERICAN JOURNAL OF MEDICINE (2023)
10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients - The Fushimi AF Registry -
Masaharu Akao et al.
CIRCULATION JOURNAL (2022)
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
Gregory Y. H. Lip et al.
CLINICAL RESEARCH IN CARDIOLOGY (2022)
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
Menno Huisman et al.
CLINICAL RESEARCH IN CARDIOLOGY (2022)
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients
Giulio Francesco Romiti et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry
Valentina Bayer et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation Findings From the Get With The Guidelines-Atrial Fibrillation Registry
Utibe R. Essien et al.
JAMA CARDIOLOGY (2022)
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs
Paul Burdett et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)
Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE Registry
Kevin Gu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Disparities in atrial fibrillation management: Is race to blame?
Brian Olshansky et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment
Jiaxi Zhao et al.
PLOS MEDICINE (2021)
Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
Utibe R. Essien et al.
JAMA NETWORK OPEN (2021)
Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China
Hong-Qiu Gu et al.
JAMA NETWORK OPEN (2021)
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry
Miney Paquette et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study
Ting Liu et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients
Yacob G. Tedla et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)
The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea
Kyung-Bok Son
BMC PUBLIC HEALTH (2020)
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
Yutao Guo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
Sylvia Haas et al.
AMERICAN HEART JOURNAL (2019)
Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation
Wen-Han Cheng et al.
STROKE (2019)
Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study
Minjae Yoon et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program
Michal Mazurek et al.
AMERICAN HEART JOURNAL (2019)
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
Tze-Fan Chao et al.
EUROPEAN HEART JOURNAL (2019)
Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation
Min Soo Cho et al.
STROKE (2019)
A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation
J. Campbell Cowan et al.
EUROPEAN HEART JOURNAL (2018)
Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
Marco Proietti et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE
Shinya Goto et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2018)
Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective
Christopher X. Wong et al.
HEART LUNG AND CIRCULATION (2017)
The ABC pathway: an integrated approach to improve AF management
Gregory Y. H. Lip
NATURE REVIEWS CARDIOLOGY (2017)
Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
So-Ryoung Lee et al.
PLOS ONE (2017)
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
Sylvia Haas et al.
PLOS ONE (2016)
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Gregory Y. H. Lip et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis
Kang-Ling Wang et al.
STROKE (2015)
Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Shinya Goto et al.
AMERICAN HEART JOURNAL (2014)
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
Menno V. Huisman et al.
AMERICAN HEART JOURNAL (2014)
Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial
Ka Sing Lawrence Wong et al.
STROKE (2014)
New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
Oh Young Bang et al.
JOURNAL OF STROKE (2014)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Dabigatran Versus Warfarin Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation
Masatsugu Hori et al.
STROKE (2013)
Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
Albert Yuh-Jer Shen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Share Paper
